1. Date of Report (Date of earliest event reported)
Jul 5, 2023
2. SEC Identification Number
3. BIR Tax Identification No.
4. Exact name of issuer as specified in its charter
5. Province, country or other jurisdiction of incorporation
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
21st Floor, Udenna Tower, Rizal Drive corner 4th Avenue, Bonifacio Global City, Taguig City Postal Code 1634
8. Issuer's telephone number, including area code
9. Former name or former address, if changed since last report
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common 14,035,000,000
11. Indicate the item numbers reported herein
Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

DITO CME Holdings Corp.DITO

PSE Disclosure Form 4-24 - Results of Annual or Special Stockholders' Meeting References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure

Results of the Annual Stockholders' Meeting of DITO held on 5 July 2023

Background/Description of the Disclosure

DITO held its Annual Stockholders' Meeting on 5 July 2023 via videoconferencing.

List of elected directors for the ensuing year with their corresponding shareholdings in the Issuer
Name of Person Shareholdings in the Listed Company Nature of Indirect Ownership
Direct Indirect
Dennis A. Uy 6,375,323 5,226,806,650 Through Udenna Corporation
Ernesto R. Alberto 3,500,000 0 -
Joseph John L. Ong 1,113,501 0 -
Cherylyn C. Uy 10,000 1,492,893,350 Through Udenna Corporation
Eric O. Recto 1,000,000 890,615 Through Monfortino Holdings Inc.
Raouf A. Kizilbash 1 0 -
Enrico S. Cruz 100 0 -
Jonathan L. Ravelas 5,000 0 -
Salvador C. Medialdea 1,000 0 -
External auditor Punongbayan & Araullo
List of other material resolutions, transactions and corporate actions approved by the stockholders

The stockholders approved the following:

1. Review and Approval of the Minutes of the Previous Meeting held on 6 December 2022
2. Approval of the Audited Financial Statements for 2022
3. Ratification of Acts of the Board of Directors and Management since the Last Annual Stockholders’ Meeting held on 6 December 2022
4. Election of Directors (including independent directors)
5. Approval of the merger of the Company with its wholly-owned subsidiary, Udenna Communications, Media and Entertainment Holdings Corp.
6. Approval of authority to act as surety and/or guarantor for its subsidiaries at the terms and conditions approved by the Board of Directors
7. Approval of issuance of shares pursuant to an equity offering, private placement, top-up placement or similar transaction to be determined by the Board and the listing of such shares.
8. Approval for the offer for sale and issuance of convertible bonds (the “Convertible Bonds”) to such number of investors to be determined by the Board of Directors, and the delegation of authority to the Board of Directors to negotiate and determine the terms and conditions of the issuance, including the transaction price, the terms and conditions of the issuance, and to engage the services of arrangers, advisors, legal counsel, and other agents as may be necessary, proper or desirable for the transaction, and the approval for the listing of the underlying common shares of the Convertible Bonds with the PSE.
9. Appointment of External Auditor

Other Relevant Information

Messrs. Cruz and Ravelas and Atty. Medialdea were elected as independent directors.

The details of the issuance of shares pursuant to an equity offering, private placement, top-up placement or similar transaction, the offer for sale and issuance of convertible bonds as well as the merger with Udenna CME are still to be determined subject to the approval of the Board of Directors.

Please see attached SEC Form 17-C.

Filed on behalf by:
Name Alyssa Hannah Nuqui
Designation Associate Legal Counsel